Profit Share Payments. Any amounts owed by Precigen pursuant to Section 6.2(a)(i) or Section 6.2(b) shall be payable in accordance with Section 6.5(g).
Profit Share Payments. In partial consideration for the rights and licenses granted to Praxis hereunder, Praxis will pay to RogCon the percentages of Net Profits as set forth in TABLE 1 below (collectively, the “Profit Share Payments”)-. TABLE 1 Timing Percentage of Net Profits For all Net Profits generated during the period beginning on the Effective Date and ending on March 31 of the Calendar Year following the first Calendar Year in which annual, worldwide Net Product Revenues first exceed [***] [***] For all Net Profits generated during the period beginning on April 1 of the Calendar Year following the first Calendar Year in which annual, worldwide Net Product Revenues first exceed [***] and until March 31 of the Calendar Year following the first Calendar Year in which annual, worldwide Net Product Revenues first exceed [***] [***] For all Net Profits generated during the period beginning on April 1 of the Calendar Year following the first Calendar Year in which annual, worldwide Net Product Revenues first [***] [***] For the avoidance of doubt, even if annual, worldwide Net Product Revenues never exceed [***], Praxis will still pay to RogCon [***] of all Net Profits generated after the Effective Date.
Profit Share Payments. Licensee shall pay to Citius fifty percent (50%) of the Product EBITDA generated during each Fiscal Quarter during the Term (the “Profit Share Payments”). Each Profit Share Payment shall be accompanied by the Profit Share Statement described in Section 7.2. Profit Share Payments shall be made on a quarterly basis and shall be paid not later than forty-five (45) days following the end of each Fiscal Quarter, and are subject to offset as set forth in Section 6.3 below.
Profit Share Payments. 5.4.1. Subject to the provisions of Section 5.5, Pfizer shall pay to OPKO gross profit payments in the amount of the marginal rates set forth below of the aggregate Franchise Gross Profit in *** with respect to Licensed Product and Genotropin Product in *** during the *** Profit Share Term***, as applicable, determined as set forth below, based on the percentage of annual Franchise Net Sales attributable to Licensed Product in ***. Each marginal gross profit payment rate set forth in the table shall apply only to that portion of the Franchise Net Sales that falls within the indicated range. Franchise Gross Profits for partial calendar years shall be determined by prorating the annual aggregate
Profit Share Payments. In each Calendar Year during the Term, Wxxxxx shall pay Adamis [*] percent ([*]%) of the first [*] ($[*]) of Net Profit, and [*] percent ([*]%) of any Net Profit in excess of [*] ($[*]). [*]. Each payment due hereunder shall be made within [*] ([*]) days of the end of each Calendar Quarter and shall be accompanied by a written report setting forth in reasonable detail the quantity of Product sold in the Territory (as measured in saleable units of Product) and Wxxxxx’x calculations of Net Sales and Net Profit for such period. In addition, the Parties shall in good faith discuss what additional reports, if any, that Wxxxxx may be able to provide with respect to the Net Sales and Net Profit earned during the preceding Calendar Quarter. Any adjustments to be made in respect of payments previously made to Adamis due to rebates, returns and the like, shall be factored into the calculation of subsequent payments.
Profit Share Payments. Following the First Commercial Sale of an Optioned Licensed Product in the United States and throughout the remainder of the Term for such Optioned Licensed Product, Xencor shall be entitled to receive [...***...]% of Gross Profits on sales of such Optioned Licensed Product in the United States in accordance with the procedure set forth in Section 10.3 below.
Profit Share Payments. In the event that CANbridge receives any Profit Share Payment from Profit Share Sublicensees in any Calendar Quarter during the Royalty Term in any country in the Licensed Territory other than in Europe and Japan, then CANbridge will pay to AVEO [**]% of such Profit Share Payment within [**] days following the end of such Calendar Quarter. CANbridge will provide to AVEO concurrently with such payment a statement setting forth the amount of Profit Share Payments received during such Calendar Quarter (including such amounts expressed in local currency and as converted to Dollars).
Profit Share Payments. In consideration of the provision of the Performance Activities, the Company shall make quarterly payments to the Service Provider in amounts equal to 17.5% of the gross profit attributable to the Products (each such quarterly payment a “Profit Share Payment”), calculated as Net Revenue from distributors and Retailers, excluding (i) the channels listed on Schedule A and (ii) sales originated by Company personnel from distributors and Retailers, less costs of goods sold, which such deduction shall include costs allocated to copackers, raw material, component providers and freight (“Gross Profit”). For the avoidance of doubt, point of sale/display fees and retail program costs shall be borne by the Company and shall not be included in the calculation of Gross Profit; provided, however such fees shall be included in the calculation of Gross Profit if they exceed $1.00 per case of the Products. Notwithstanding anything to the contrary herein, any Profit Share Payments otherwise due and payable in respect of that portion of the sales of the Products that exceed 25,000 cases in a given month shall be reduced by any un-reimbursed advances made pursuant to Section 1.1.
Profit Share Payments. Following the First Commercial Sale of a Collaboration Product in the Profit Share Territories and throughout the remainder of the Term for such Collaboration Product, each Party who is not the Lead Commercialization Party shall be entitled to receive their respective Commercial Sharing Percentage of Gross Profits on sales of such Collaboration Product in the Profit Share Territory, as applicable to each Region within the Profit Share Territory. To give effect to the foregoing:
Profit Share Payments. Where the Profit Share Trigger has occurred for a Licensed Product, Virpax shall make quarterly payments to Nanomerics in accordance with Section 7.13 equal to the Applicable Profit Share Percentage of [**] (the “Profit Share Payments”) for such Licensed Product. To the extent the calculation of [**] for a Calendar Quarter results in a negative amount, Virpax may carry over and deduct such amount in calculating Licensed Product Net Operating Profit for future Calendar Quarters. For any subsequent Calendar Quarter after the payment of a Profit Share Payment, Virpax may adjust and re-calculate the Profit Share Payments for prior Calendar Quarters due to additional events affecting the calculation of [**], such as returns, chargebacks, fees assessed, liabilities associated with a Licensed Product, or other deductions not previously captured.
